PT - JOURNAL ARTICLE AU - Gold, Jeffrey P. AU - Wichman, Christopher AU - Bayles, Kenneth AU - Khan, Ali S. AU - Kratochvil, Christopher AU - Lawler, James V. AU - Lowe, John Martin AU - Schwedhelm, Shelly AU - Grimm, Brandon TI - A Novel Approach to Data Driven Pandemic Recovery: The Pandemic Recovery Acceleration Model AID - 10.1101/2020.05.17.20104695 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.17.20104695 4099 - http://medrxiv.org/content/early/2020/05/22/2020.05.17.20104695.short 4100 - http://medrxiv.org/content/early/2020/05/22/2020.05.17.20104695.full AB - A data driven approach to guide the global, regional and local pandemic recovery planning is key to the safety, efficacy and sustainability of all pandemic recovery efforts. The Pandemic Recovery Acceleration Model (PRAM) analytic tool was developed and implemented state wide in Nebraska to allow health officials, public officials, industry leaders and community leaders to capture a real time snapshot of how the COVID-19 pandemic is affecting their local community, a region or the state and use this novel lens to aid in making key mitigation and recovery decisions. This is done by using six commonly available metrics that are monitored daily across the state describing the pandemic impact: number of new cases, percent positive tests, deaths, occupied hospital beds, occupied intensive care beds and utilized ventilators, all directly related to confirmed COVID-19 patients.Nebraska is separated into six Health Care Coalitions based on geography, public health and medical care systems. The PRAM aggregates the data for each of these geographic regions based on disease prevalence acceleration and health care resource utilization acceleration, producing real time analysis of the acceleration of change for each metric individually and also combined into a single weighted index, the PRAM Recovery Index. These indices are then shared daily with the state leadership, coalition leaders and public health directors and also tracked over time, aiding in real time regional and statewide decisions of resource allocation and the extent of use of comprehensive non-pharmacologic interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNebraska Electronic Disease Surveillance System data availability is subject to the approval of the Nebraska Department of Health and Human Services: 301 Centennial Mall South, Lincoln, Nebraska 68509. Knowledge Center data availability is subject to the approval of the Nebraska Emergency Management Agency: 2433 NW 24th Street, Lincoln, Nebraska 68524-1801. Programming code is available by contacting Chris Wichman at 984375 Nebraska Medical Center, Omaha, Nebraska 68198-4375.